Compositions for Treating Bone Diseases and Broken Bones, Brigham Young University, EP2755661A1
Summary
The EPO published patent application EP2755661A1 for Brigham Young University on April 15, 2026, covering compositions for treating bone diseases and broken bones. The application, classified under A61K 31/575 and related pharmaceutical classes, designates 35 European states including AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, HR, HU, IE, IT, LI, LT, LU, MC, NL, NO, PL, PT, RO, SE, SI, SK, and SM. Inventors are Carl Genberg and Paul B. Savage.
About this source
GovPing monitors EPO Patent Bulletin - Pharma (A61K) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 49 changes logged to date.
What changed
The EPO published patent application EP2755661A1, a pharmaceutical composition patent for treating bone diseases and fractures. The application claims priority classifications under A61K 31/575 (steroid-based compositions), A61K 45/06 (drug combinations), and A61K 38/18 (growth factor compositions), with therapeutic indications spanning bone disease, arthritis, bone fractures, osteoporosis, and anti-inflammatory applications under A61P classifications.
Parties seeking to develop or commercialize bone disease treatments in Europe should review this application for potential licensing needs or freedom-to-operate analysis, particularly in jurisdictions designated in the filing.
Archived snapshot
Apr 23, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
COMPOSITIONS FOR TREATING BONE DISEASES AND BROKEN BONES
Publication EP2755661A1 Kind: A1 Apr 15, 2026
Applicants
Brigham Young University
Inventors
GENBERG, Carl, SAVAGE, Paul, B.
IPC Classifications
A61K 31/575 20060101AFI20250827BHEP A61K 45/06 20060101ALI20250827BHEP A61K 38/18 20060101ALI20250827BHEP A61P 19/00 20060101ALI20250827BHEP A61P 19/02 20060101ALI20250827BHEP A61P 19/08 20060101ALI20250827BHEP A61P 19/10 20060101ALI20250827BHEP A61P 31/00 20060101ALI20250827BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Get daily alerts for EPO Patent Bulletin - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.